European Archives - Page 609 of 1122 - European Medical Journal

Continue
Derm 8.1 feature image
1 Mins
15 Dec 2020

Skin Toxicity Caused by Sequential Treatment with PD-1 Inhibitor and mTOR Inhibitor

Immune checkpoint inhibitors and mTOR inhibitors are known to be associated with skin toxicity…
Derm 8.1 feature image
December 2020

EMJ Dermatology 8.1 2020

The latest issue of EMJ Dermatology includes our review of European Academy of Dermatology and Venereology 2020 Virtual Congress with abstract summaries, insightful interviews, and breaking news in this field.
Derm 8.1 feature image
8 Mins
15 Dec 2020

European Academy of Dermatology and Venereology (EADV) 2020 Virtual Congress

VIENNA, Austria, is a city with unquestionable spirit, influence, and grandiosity, and would have been a spectacular host to this year’s European Academy of Dermatology and Venereology (EADV) 29th Congress…
8 Mins
15 Dec 2020

The Other Side of the Moon: A Clinical Dialogue on the IL-23 Pathway

Prof Reich began by highlighting how insights into the pathophysiology of psoriasis have led to the development and expansion of cytokine-targeted…
Derm 8.1 feature image
2 Mins
15 Dec 2020

Mycobacterium bovis Infection Mimicking Pyoderma Gangrenosum and Inflammatory Bowel Disease in an Elderly Male

Cutaneous ulceration presents many challenges to the dermatologist and multidisciplinary team due to a broad differential diagnosis, difficult management decisions, and delayed wound healing…
Derm 8.1 feature image
1 Mins
15 Dec 2020

Coping Strategies as Predictors of Stress and Anxiety in Caregivers of Patients with Severe Drug Allergy

The unpredictability and fear of potentially life-threatening allergic reactions influences the occurrence and manifestation of anxiety in patients with severe drug allergy, as well as their family members…
Derm 8.1 feature image
6 Mins
15 Dec 2020

Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from EADV 2020

The VOYAGE 1 trial1 was a placebo- and active-controlled Phase III study to evaluate long-term efficacy and safety of the IL-23p19 inhibitor guselkumab…
Derm 8.1 feature image
2 Mins
15 Dec 2020

Comparison of Total Body Nevus Count in Patients with Multiple Primary Melanoma and Single Primary Melanoma: A Prospective Single Centre Study

A high number of benign melanocytic nevi has been implicated as a major risk factor for melanoma development;1 however, there are sparse data on the total body nevus count (TBNC) and its relation to the propensity for multiple primary melanomas…
Derm 8.1 feature image
8 Mins
15 Dec 2020

Bimekizumab Efficacy and Safety in Patients with Moderate-to-Severe Plaque Psoriasis

Psoriasis is a Th17-driven disease, with both IL-17A and IL-17F playing a pivotal role in its pathogenesis.2,3 BKZ is a monoclonal IgG1 antibody…
5 Mins
15 Dec 2020

EADV Congress Interview: Prof Alexander Stratigos

I became involved in dermatology for various reasons, but what really attracted me was the impressive range and diversity of the specialty…
We’ve noticed you’re accessing
from North/South America.